Bull looks for Alkermes to bounce

By
A A A

The bears have driven Alkermes to a key support level, and now one investor is positioning for a rebound.


ALKS ALKS rose 3.13 percent to $11.22 in afternoon trading. The drug-delivery stock is down 20 percent since March 15, when it gapped higher on optimism about the Bydureon diabetes treatment. Two months later, it plunged on a weak earnings report and has been trapped below $12 since.

Today's option trade, known as a bullish combination, will mimic a long position in the stock and appeared after ALKS bounced off its 200-day moving average. The strategy will double the investor's money for every $0.25 that the stock trades over $12.75 and lose money below $10.

The company is scheduled to make a presentation at the Bank of America Merrill Lynch Small and Mid-Cap Conference at 2:30 p.m. ET today and at the Jefferies Global Life Sciences Conference at 4:30 p.m. ET tomorrow.

Overall options volume in ALKS is 30 times greater than average so far today.

 

(Chart courtesy of tradeMONSTER )

 



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.



This article appears in: Investing , Options

Referenced Stocks: ALKS

optionMONSTER

optionMONSTER

More from optionMONSTER:

Related Videos

Stocks

Referenced

Most Active by Volume

74,114,159
  • $15.42 ▲ 0.06%
46,673,879
  • $24.12 ▲ 0.50%
45,895,235
  • $27.09 ▼ 1.35%
45,875,223
  • $124.24 ▲ 0.70%
44,718,067
  • $30.08 ▲ 0.64%
44,236,338
  • $105.10 ▼ 0.34%
44,210,124
  • $5.79 ▼ 3.98%
42,764,501
  • $26.66 ▲ 0.34%
As of 3/26/2015, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com